Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...